NCT06325670View on ClinicalTrials.gov

Type 2 Diabetes and Binge Eating Disorder (BED)

NAActive, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Diabetes Mellitus, Type 2Binge-Eating Disorder
Interventions
BEHAVIORAL

BED treatment

A 12 session cognitive behavioural intervention in groups for Danish adults with type 2 diabetes and Binge Eating Disorder.

OTHER

Waitlist

A waitlist control group that receives regular type 2 diabetes treatment while waiting to receive the BED treatment intervention.

Trial Locations (1)

5000

Region Of Southern Denmark Locations, Odense

All Listed Sponsors
collaborator

Jascha Fonden

OTHER

collaborator

Independent Research Fund Denmark

INDUSTRY

lead

Odense University Hospital

OTHER

NCT06325670 - Type 2 Diabetes and Binge Eating Disorder (BED) | Biotech Hunter | Biotech Hunter